H. Baumgartner, V. Falk, and J. J. Bax, , 2017.

. Esc/eacts, Guidelines for the management of valvular heart disease, Eur Heart J, vol.4, pp.2739-91, 2017.

R. A. Nishimura, C. M. Otto, and R. O. Bonow, AHA/ACC Focused Update of the 6, 2017.

. Aha/acc, Guideline for the Management of Patients With Valvular Heart Disease: A 7 Report of the American College of Cardiology, American Heart Association Task Force on, vol.8

, Clinical Practice Guidelines. Circulation, vol.135, pp.1159-95, 2017.

A. P. Kappetein, S. J. Head, and P. Généreux, Updated standardized endpoint definitions 10 for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 11 consensus document, J Am Coll Cardiol, vol.60, pp.1438-54, 2012.

E. Durand, B. Borz, and M. Godin, Transfemoral aortic valve replacement with the 13

S. Edwards, S. Edwards, and . Xt, prosthesis using exclusively local anesthesia and 14 fluoroscopic guidance: feasibility and thirty-day outcomes, JACC Cardiovasc Interv, vol.15, pp.461-468, 2012.

E. Durand, H. Eltchaninoff, and A. Canville, Feasibility and safety of early discharge 17 after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT 18 prosthesis, Am J Cardiol, vol.115, pp.1116-1138, 2015.

A. Serletis-bizios, E. Durand, and G. Cellier, Prospective Analysis of Early, vol.20

, Discharge After Transfemoral Transcatheter Aortic Valve Implantation, Am J Cardiol, vol.21, pp.866-72, 2016.

M. Barbanti, P. Capranzano, and Y. Ohno, Early discharge after transfemoral 23 transcatheter aortic valve implantation, Heart, vol.101, pp.1485-90, 2015.